Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Kathleen A, Ross"'
Autor:
Christopher E. Lopez, Zeb R. Zacharias, Kathleen A. Ross, Balaji Narasimhan, Thomas J. Waldschmidt, Kevin L. Legge
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-14 (2024)
Abstract Influenza A virus (IAV) causes significant morbidity and mortality worldwide due to seasonal epidemics and periodic pandemics. The antigenic drift/shift of IAV continually gives rise to new strains and subtypes, aiding IAV in circumventing p
Externí odkaz:
https://doaj.org/article/287eb466d055478badd3a682ea9675c4
Autor:
Kathleen A. Ross, April M. Tingle, Sujata Senapati, Kaitlyn G. Holden, Michael J. Wannemuehler, Surya K. Mallapragada, Balaji Narasimhan, Marian L. Kohut
Publikováno v:
Immunity & Ageing, Vol 20, Iss 1, Pp 1-14 (2023)
Abstract Background Age-associated impairments of immune response and inflammaging likely contribute to poor vaccine efficacy. An appropriate balance between activation of immune memory and inflammatory response may be more effective in vaccines for
Externí odkaz:
https://doaj.org/article/f0c209bd78e644a7b9ea9b965e400f32
Autor:
Jessie A. Gleason, Kathleen M. Ross
Publikováno v:
Emerging Infectious Diseases, Vol 28, Iss 3, Pp 625-630 (2022)
Incidence of Legionnaires’ disease is increasing, particularly in the Mid-Atlantic states in the United States; since 2015, New Jersey has documented ≈250–350 legionellosis cases per year. We used SaTScan software to develop a semiautomated sur
Externí odkaz:
https://doaj.org/article/13fb827b6f004511991f75affe2e451c
Autor:
Yashdeep Phanse, Supraja Puttamreddy, Duan Loy, Julia Vela Ramirez, Kathleen A. Ross, Ignacio Alvarez-Castro, Mark Mogler, Scott Broderick, Krishna Rajan, Balaji Narasimhan, Lyric C. Bartholomay
Publikováno v:
Vaccines, Vol 10, Iss 9, p 1428 (2022)
In the last 15 years, crustacean fisheries have experienced billions of dollars in economic losses, primarily due to viral diseases caused by such pathogens as white spot syndrome virus (WSSV) in the Pacific white shrimp Litopenaeus vannamei and Asia
Externí odkaz:
https://doaj.org/article/4f8e29c5e985486a8229ccf124c67149
Autor:
Madelyn Espinosa-Cotton, Samuel N. Rodman III, Kathleen A. Ross, Isaac J. Jensen, Kenley Sangodeyi-Miller, Ayana J. McLaren, Rachel A. Dahl, Katherine N. Gibson-Corley, Adam T. Koch, Yang-Xin Fu, Vladimir P. Badovinac, Douglas Laux, Balaji Narasimhan, Andrean L. Simons
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-16 (2019)
Abstract Background Despite the high prevalence of epidermal growth factor receptor (EGFR) overexpression in head and neck squamous cell carcinomas (HNSCCs), incorporation of the EGFR inhibitor cetuximab into the clinical management of HNSCC has not
Externí odkaz:
https://doaj.org/article/506a541666684f3397618ae8f721a1c9
Publikováno v:
International Journal of Health Geographics, Vol 16, Iss 1, Pp 1-11 (2017)
Abstract Background Although the incidence of legionellosis throughout North America and Europe continues to increase, public health investigations have not been able to identify a common exposure in most cases. Over 80% of cases are sporadic with no
Externí odkaz:
https://doaj.org/article/d07fb8152b534462bf1bd2ab59b0d90e
Autor:
Alaric C. Siddoway, David Verhoeven, Kathleen A. Ross, Michael J. Wannemuehler, Surya K. Mallapragada, Balaji Narasimhan
Publikováno v:
ACS Biomaterials Science & Engineering. 8:2500-2507
Seasonal influenza A virus infections present substantial costs to both health and economic resources each year. Current seasonal influenza vaccines provide suboptimal protection and require annual reformulation to match circulating strains. In this
Publikováno v:
J Virol
Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infections in children. In humans, natural infection with RSV affords only partial long-term protection from reinfection, and there is no licensed RSV vaccine currently
Autor:
Zeb R. Zacharias, Kathleen A. Ross, Emma E. Hornick, Jonathan T. Goodman, Balaji Narasimhan, Thomas J. Waldschmidt, Kevin L. Legge
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Influenza A virus (IAV) is a major cause of respiratory illness. Given the disease severity, associated economic costs, and recent appearance of novel IAV strains, there is a renewed interest in developing novel and efficacious “universal” IAV va
Externí odkaz:
https://doaj.org/article/35d155b9836c4a4a847e5cae98b816d5
Autor:
Kevin L. Legge, Kathleen A. Ross, Kody A Waldstein, Steven M. Varga, Laura M Stephens, Balaji Narasimhan, Jason S. McLellan
Publikováno v:
J Immunol
Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infection in both young children and in older adults. Despite the morbidity, mortality, and high economic burden caused by RSV worldwide, no licensed vaccine is currently